Johnny Arnsdorf

Johnny Arnsdorf

Auto-generated profile, based on publicly available information

Johnny Arnsdorf

The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Hørsholm, Denmark

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Cell Systems
Verified
Journal Article
Closed access
HHHooman Hefzi
Hooman Hefzi
KAKok Siong Ang
Kok Siong Ang
MHMichael Hanscho
Michael Hanscho
ABAarash Bordbar
Aarash Bordbar
DRDavid Ruckerbauer
David Ruckerbauer
NLNathan Lewis
Nathan Lewis

1 January 1998 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TATimothy E. Adams
Timothy E. Adams
JHJohnny A. Hansen
Johnny A. Hansen
RSRobyn Starr
Robyn Starr
NNNicos A. Nicola
Nicos A. Nicola
DHDouglas J. Hilton
Douglas J. Hilton
NBNils Billestrup
Nils Billestrup
Four members (SOCS-1, SOCS-2, SOCS-3, and CIS) of a family of cytokine-inducible, negative regulators of cytokine receptor signaling have recently been identified. To address whether any of these genes are induced in response to growth hormone (GH), serum-starved 3T3-F442A fibroblasts were incubated with GH for various time points, and the expression of the SOCS gene family was analyzed by Northern blotting. GH stimulated the rapid, transient induction ofSOCS-3 mRNA, peaking 30 min after the initiation of GH exposure and declining to basal levels by 2 h. Expression of the other SOCS genes (SOCS-1, SOCS-2,CIS) was also up-regulated by GH, although to a lesser extent than SOCS-3 and with differing kinetics.SOCS-3 expression was also strongly induced in 3T3-F442A cells treated with leukemia-inhibitory factor (LIF), with weaker induction of SOCS-1 and CIS being observed. The preferential induction of SOCS-3 mRNA was also observed in hepatic RNA isolated from the livers of mice that had received a single supraphysiological dose of GH intraperitoneally. Co-transfection studies revealed that constitutive expression of SOCS-1 and SOCS-3, but not SOCS-2 or CIS, blocked GH-induced transactivation of the GH-responsive serine protease inhibitor 2.1 gene promoter.

20 April 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
SKStefan Kol
Stefan Kol
DLDaniel Ley
Daniel Ley
TWTune Wulff
Tune Wulff
MDMarianne Decker
Marianne Decker
JAJohnny Arnsdorf
Johnny Arnsdorf
NLNathan Lewis
Nathan Lewis
Host cell proteins (HCPs) are process-related impurities generated during biotherapeutic protein production. HCPs can be problematic if they pose a significant metabolic demand, degrade product quality, or contaminate the final product. Here, we present an effort to create a “clean” Chinese hamster ovary (CHO) cell by disrupting multiple genes to eliminate HCPs. Using a model of CHO cell protein secretion, we predict that the elimination of unnecessary HCPs could have a non-negligible impact on protein production. We analyze the HCP content of 6-protein, 11-protein, and 14-protein knockout clones. These cell lines exhibit a substantial reduction in total HCP content (40%-70%). We also observe higher productivity and improved growth characteristics in specific clones. The reduced HCP content facilitates purification of a monoclonal antibody. Thus, substantial improvements can be made in protein titer and purity through large-scale HCP deletion, providing an avenue to increased quality and affordability of high-value biopharmaceuticals.

1 January 2016 in Metabolic Engineering
Verified
Journal Article
Closed access
PSPhilipp N. Spahn
Philipp N. Spahn
AHAnders Holmgaard Hansen
Anders Holmgaard Hansen
HHHenning G. Hansen
Henning G. Hansen
JAJohnny Arnsdorf
Johnny Arnsdorf
HKHelene F. Kildegaard
Helene F. Kildegaard
NLNathan Lewis
Nathan Lewis

1 May 2003 in Molecular Endocrinology
Verified
Journal Article
Closed access
BFBirgitte N. Friedrichsen
Birgitte N. Friedrichsen
HRHenrijette E. Richter
Henrijette E. Richter
JHJohnny A. Hansen
Johnny A. Hansen
CRChristopher J. Rhodes
Christopher J. Rhodes
Jens NielsenJens Nielsen
Jens Nielsen
AMAnnette Møldrup
Annette Møldrup
Signal transducer and activator of transcription 5 (STAT5) activation plays a central role in GH- and prolactin-mediated signal transduction in the pancreatic β-cells. In previous experiments we demonstrated that STAT5 activation is necessary for human (h)GH-stimulated proliferation of INS-1 cells and hGH-induced increase of mRNA-levels of the cell cycle regulator cyclin D2. In this study we have further characterized the role of STAT5 in the regulation of cyclin D expression and β-cell proliferation by hGH. Cyclin D2 mRNA and protein levels (but not cyclin D1 and D3) were induced in a time-dependent manner by hGH in INS-1 cells. Inhibition of protein synthesis by coincubation with cycloheximide did not affect the hGH-induced increase of cyclin D2 mRNA levels at 4 h. Expression of a dominant negative STAT5 mutant, STAT5aΔ749, partially inhibited cyclin D2 protein levels. INS-1 cells transiently transfected with a cyclin D2 promoter-reporter construct revealed a 3- to 5-fold increase of transcriptional activity in response to hGH stimulation. Furthermore, coexpression of a constitutive active STAT5 mutant (either CA-STAT5a or CA-STAT5b) was sufficient to drive transactivation of the promoter. CA-STAT5b was stably expressed in INS-1 cells under the control of a doxycycline-inducible promoter. Gel retardation experiments using a probe representing a putative STAT5 binding site in the cyclin D2 promoter revealed binding of the doxycycline-induced CA-STAT5b. Furthermore, induction of CA-STAT5b stimulated transcriptional activation of the cyclin D2 promoter and induced hGH-independent proliferation in these cells. In primary β-cells, adenovirus-mediated expression of CA-STAT5b profoundly stimulated DNA-synthesis (5.3-fold over control) in the absence of hGH. Our studies indicate that STAT5 activation is sufficient to drive proliferation of the β-cells and that cyclin D2 may be a critical target gene for STAT5 in this process.

1 March 2019 in Metabolic Engineering
Verified
Journal Article
Closed access
TAThomas Amann
Thomas Amann
AHAnders Holmgaard Hansen
Anders Holmgaard Hansen
SKStefan Kol
Stefan Kol
HHHenning Gram Hansen
Henning Gram Hansen
JAJohnny Arnsdorf
Johnny Arnsdorf
HKHelene Faustrup Kildegaard
Helene Faustrup Kildegaard